Literature DB >> 7075944

Mortality in ulcerative colitis.

S Gyde, P Prior, M J Dew, V Saunders, J A Waterhouse, R N Allan.   

Abstract

The pattern of mortality has been examined in a series of 676 patients with ulcerative colitis under long-term review to identify excesses or deficits in mortality for all causes of death in relation to the general population. The mortality risk for the whole series was 1.7 times that of the general population (p less than 0.001). Most of the excess mortality could be attributed to diseases of the digestive system. There was a heavy burden of mortality during the first year afer diagnosis and the first year after radical surgery. The significance of the excess of cancer deaths was due to the inclusion of patients who were diagnosed with cancer at first referral. In man there was a deficit of circulatory system deaths particularly those with early onset ulcerative colitis treated by panproctocolectomy after 40 yr of age. Mortality from all other causes including breast cancer showed no significant difference from that expected in the general population.

Entities:  

Mesh:

Year:  1982        PMID: 7075944

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  37 in total

Review 1.  Role of smoking in inflammatory bowel disease: implications for therapy.

Authors:  G A Thomas; J Rhodes; J T Green; C Richardson
Journal:  Postgrad Med J       Date:  2000-05       Impact factor: 2.401

2.  Current management of inflammatory bowel disease and colorectal cancer.

Authors:  Mark C Mattar; Denver Lough; Michael J Pishvaian; Aline Charabaty
Journal:  Gastrointest Cancer Res       Date:  2011-03

Review 3.  Molecular Alterations of Colorectal Cancer with Inflammatory Bowel Disease.

Authors:  Masakazu Yashiro
Journal:  Dig Dis Sci       Date:  2015-04-04       Impact factor: 3.199

Review 4.  Ulcerative colitis-associated colorectal cancer.

Authors:  Masakazu Yashiro
Journal:  World J Gastroenterol       Date:  2014-11-28       Impact factor: 5.742

Review 5.  A meta-analysis of the clinicopathological characteristics and survival outcomes of inflammatory bowel disease associated colorectal cancer.

Authors:  Ian S Reynolds; Aobhlinn O'Toole; Joseph Deasy; Deborah A McNamara; John P Burke
Journal:  Int J Colorectal Dis       Date:  2017-01-11       Impact factor: 2.571

6.  The risk of colorectal cancer in ulcerative colitis: a meta-analysis.

Authors:  J A Eaden; K R Abrams; J F Mayberry
Journal:  Gut       Date:  2001-04       Impact factor: 23.059

7.  Mortality Risk of Inflammatory Bowel Disease: A Case-Control Study of New York State Death Records.

Authors:  Angelica Nocerino; Alexandra Feathers; Elena Ivanina; Laura Durbin; Arun Swaminath
Journal:  Dig Dis Sci       Date:  2019-01-02       Impact factor: 3.199

8.  Crohn's disease and ulcerative colitis are associated with elevated standardized mortality ratios: a meta-analysis.

Authors:  Meenakshi Bewtra; Lisa M Kaiser; Tom TenHave; James D Lewis
Journal:  Inflamm Bowel Dis       Date:  2013-03       Impact factor: 5.325

9.  Transition from colitis to cancer: high Wnt activity sustains the tumor-initiating potential of colon cancer stem cell precursors.

Authors:  Anitha K Shenoy; Robert C Fisher; Elizabeth A Butterworth; Liya Pi; Lung-Ji Chang; Henry D Appelman; Myron Chang; Edward W Scott; Emina H Huang
Journal:  Cancer Res       Date:  2012-08-17       Impact factor: 12.701

Review 10.  Colitis-associated cancer: the role of T cells in tumor development.

Authors:  Maximilian J Waldner; Markus F Neurath
Journal:  Semin Immunopathol       Date:  2009-06-03       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.